Spinal cord injury

NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update

Retrieved on: 
Tuesday, April 2, 2024
ODD, Research, Growth, Drug discovery, Exercise, NRX, CFO, RNA, Laboratory, Contract research organization, Regenerative medicine, Investigational New Drug, Safety, Spinal cord injury, Intellectual property, Plasma protein binding, Small RNA, FDA, Food, Cryptocurrency

TORONTO and HAIFA, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing regenerative medicine therapies, today provided a business update and reported financial results for the fourth quarter and financial year ended December 31, 2023.

Key Points: 
  • TORONTO and HAIFA, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing regenerative medicine therapies, today provided a business update and reported financial results for the fourth quarter and financial year ended December 31, 2023.
  • For the fourth quarter of 2023, expenses were US$0.31 million, compared to US$0.39 million in the previous year.
  • For the fourth quarter of 2023, expenses were US$0.40 million, compared to US$0.46 million in the previous year.
  • For the fourth quarter of 2023, expenses were US$0.02 million, compared to US$0.17 million in the previous year.

In Preparation for Expected Human Clinical Trials, NurExone Signs Agreement for Large Scale Preclinical Testing for Its Spinal Cord Injury Therapy, ExoPTEN

Retrieved on: 
Friday, March 22, 2024
Drug discovery, Rat, NRX, PTEN, Patient, Contract research organization, IND, Regenerative medicine, Behavior, Spinal cord, Spinal cord injury, SCI, Pharmaceutical industry

This large-scale animal testing represents a significant step towards filing an Investigational New Drug (IND) application in the US for NurExone’s ExoPTEN therapy for spinal cord injury (SCI).

Key Points: 
  • This large-scale animal testing represents a significant step towards filing an Investigational New Drug (IND) application in the US for NurExone’s ExoPTEN therapy for spinal cord injury (SCI).
  • Under the terms of the agreement, Vivox will provide Contract Research Organization (CRO) services to NurExone, as a prerequisite to commencing Human Trials under the planned IND.
  • The testing will encompass mobility, behavior, motor and sensory recovery of rats following Spinal Cord Injury and treatment with ExoPTEN," said Dr. Lior Shaltiel, CEO of NurExone.
  • By collaborating with Vivox, NurExone aims to accelerate the development and regulatory path of ExoPTEN, to bring this potentially transformative treatment to patients in need.

ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)

Retrieved on: 
Thursday, January 25, 2024
BCI, Assistant, Spinal cord injury, ARC, Euronext, Spinal cord, NANS, Neuromodulation, DSM-IV codes, University, Kessler Foundation, SCI, De novo, Movement, Paralysis, Neurology, FDA, Chronic pain, Abstract, Medical device

The Up-LIFT pivotal study investigated non-invasive neuromodulation to improve upper extremity strength and function after SCI; ARC-EX Therapy met all primary safety and effectiveness endpoints and demonstrated a 72% responder rate1.

Key Points: 
  • The Up-LIFT pivotal study investigated non-invasive neuromodulation to improve upper extremity strength and function after SCI; ARC-EX Therapy met all primary safety and effectiveness endpoints and demonstrated a 72% responder rate1.
  • While bringing awareness to spinal cord injury during a meeting traditionally focused on chronic pain and movement disorders, Dr.
  • Guest presented clinical results and his experience from the Up-LIFT pivotal study.
  • All ONWARD devices and therapies, including but not limited to ARC-IM®, ARC-EX, and ARC Therapy, alone or in combination with BCI, are investigational and not available for commercial use.

NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market

Retrieved on: 
Wednesday, January 17, 2024
Spinal cord injury, Agreement, Patient, Advertising, Exosome, Administration, NRX, SCI, TSX Venture Exchange, Pharmaceutical industry

The collaborative agreement between NurExone and Inteligex Inc. (“Inteligex”), announced in October 2023, to expand the Company’s portfolio, is now officially underway.

Key Points: 
  • The collaborative agreement between NurExone and Inteligex Inc. (“Inteligex”), announced in October 2023, to expand the Company’s portfolio, is now officially underway.
  • As part of this collaboration, we will use our platform to produce and load exosomes from Inteligex’s cell line to deliver combination regenerative therapy for Spinal Cord Injury (SCI) patients.
  • This win-win collaboration will expand our potential markets and is in line with our belief of patient, first.”
    Dr. Paul Bradshaw, CEO of Inteligex, stated that “Spinal cord injury is the single most expensive healthcare condition in the world.
  • The Agreement is effective for four months from the effective date and the total consideration payable to BullVestor is CAD$300,000 on the effective date.

The Christopher & Dana Reeve Foundation Launches 'Outdoors for Everyone' to Promote Inclusivity, Accessibility in Nature

Retrieved on: 
Wednesday, September 13, 2023
Checklist, Christopher and Dana Reeve Foundation, U.S. Department of Defense Strategy for Operating in Cyberspace, Disability, Partner, International Association of Agricultural Information Specialists, SHORT, Spinal cord injury, Person, U.S. Department of Agriculture Cotton Annex, Guide book, Paralysis, National park, Nature, Map, Engagement, Caregiver, Nursing

SHORT HILLS, N.J., Sept. 13, 2023 /PRNewswire/ -- Today, in observance of Spinal Cord Injury Awareness Month, the Christopher & Dana Reeve Foundation launched the 'Outdoors for Everyone Campaign,' an initiative to ensure the great outdoors is equally accessible and inclusive for all people – including those living with paralysis, their families, and caregivers.

Key Points: 
  • While the beauty of nature is a universal right, the great outdoors and accessibility are oftentimes in conflict.
  • "Everyone of all abilities deserves to experience the great outdoors," said Mark Bogosian, Director of Engagement at the Reeve Foundation.
  • "The Reeve Foundation's 'Outdoors for Everyone' initiative aims to address the preventable limitations for those impacted by paralysis.
  • They also use and share the 'Accessible Outdoor Checklist' in discussions and planning to ensure an equitable lens.

New Online Course Equips Personal Care Assistants with Essential Knowledge for Supporting Individuals with Spinal Cord Injury

Retrieved on: 
Tuesday, August 15, 2023
Blood pressure, Rehabilitation Research and Development Service, MPT, Institutional review board, Tetraplegia, Paralyzed Veterans of America, Partnership, National Institute on Disability, Independent Living, and Rehabilitation Research, Spinal cord, Quality of life, Muscular Dystrophy Community Assistance Research and Education Amendments of 2001, United States Secretary of Labor, Rehabilitation, Spinal cord injury, Doctor of Philosophy, Wheelchair, The Foundation for Young Australians, NIDILRR, Focus group, Sam Schmidt Paralysis Foundation, Kessler Foundation, Shepherd Center, Disability, Independent living, Elevate, PVA, EAST, Knowledge, Collaboration, Grant, Education, Caregiver, Trapping, Nursing, Research

EAST HANOVER, N.J., Aug. 15, 2023 /PRNewswire/ -- A new interactive, online course, "Understanding Spinal Cord Injury: A Course for Personal Care Assistants," was designed to enhance the training of personal care assistants (PCAs) for individuals with spinal cord injury. The course was unveiled today at the Paralyzed Veterans of America Healthcare (PVA) Summit + Expo at the Renaissance Orlando at SeaWorld Hotel in Orlando, FL. The presentation was given by Jeanne Zanca, MPT, PhD, FACRM, assistant director of the Center for Spinal Cord Injury Research at Kessler Foundation and chair of the Foundation's Institutional Review Board.

Key Points: 
  • Launch of "Understanding Spinal Cord Injury: A Course for Personal Care Assistants," is an important step toward ensuring quality personal care assistance services for individuals with spinal cord injury
    EAST HANOVER, N.J., Aug. 15, 2023 /PRNewswire/ -- A new interactive, online course, " Understanding Spinal Cord Injury : A Course for Personal Care Assistants," was designed to enhance the training of personal care assistants (PCAs) for individuals with spinal cord injury.
  • Elevate training for personal care assistants with free, interactive online course: Understanding Spinal Cord Injury
    The course, the first specifically designed to introduce personal care assistants to spinal cord injury, is available at no cost at https://www.kflearn.org , the Foundation's site for educational and training resources for consumers and professionals.
  • Recognizing its focus on client-centered care for spinal cord injury, the North American Spinal Cord Injury Consortium (NASCIC) has endorsed the new course.
  • "Understanding Spinal Cord Injury: A Course for Personal Assistants," is a significant step towards ensuring the quality of personal care assistance services provided to individuals living with spinal cord injury," Dr. Zanca emphasized.

The University of Alberta and the Christopher & Dana Reeve Foundation Partner to Facilitate Open Data Sharing

Retrieved on: 
Friday, April 28, 2023
Faculty, Data management, Christopher and Dana Reeve Foundation, Human, International Spinal Cord Society, Partnership, University, Tetraplegia, Internet, Reusability, Policy, Quality of life, SHORT, Research, Rehabilitation, Spinal cord injury, Bangladesh Technical Education Board, Science, Paralysis, Data recovery, Laboratory, Manuscript, ODC, Accessibility, Interoperability, Reeve, European, DOI, Drug discovery, Physical medicine and rehabilitation, Open data, Health, SCI, Craig, FAIR, Pharmaceutical industry

SHORT HILLS, N.J., April 28, 2023 /PRNewswire/ -- Today, the Christopher & Dana Reeve Foundation and the University of Alberta announced a joint three-year initiative, supported by a $250,000 Reeve Foundation grant, to accelerate open data via the Open Data Commons for Spinal Cord Injury (ODC-SCI). The initiative aims to facilitate data standardization, knowledge sharing and scientific replicability and translation to spur more pre-competitive therapeutic research opportunities and reduce fundamental challenges within the research community that slow progress.

Key Points: 
  • New collaboration supports data retrieval and input into the Open Data Commons for Spinal Cord Injury, a first step toward field-enabling knowledge sharing and data transparency
    SHORT HILLS, N.J., April 28, 2023 /PRNewswire/ -- Today, the Christopher & Dana Reeve Foundation and the University of Alberta announced a joint three-year initiative, supported by a $250,000 Reeve Foundation grant, to accelerate open data via the Open Data Commons for Spinal Cord Injury (ODC-SCI).
  • The Reeve Foundation-University of Alberta partnership further supports evolving national and international policies that emphasize the importance of open data.
  • In late January, the National Institutes of Health announced its requirements for data management and sharing plans for all research generating scientific data.
  • "We're eager to see the volume of open SCI data grow over the next three years.

Dr. Praveen Reddy is recognized by Continental Who's Who

Retrieved on: 
Thursday, January 19, 2023
Adenoma, Methodist Hospital, University, Mount Sinai Beth Israel, Neurosurgery, Diagnosis, Spine, Congress, ABNS, Head, Nervous system, Congress of Neurological Surgeons, Neuro-oncology, Augmented fifth, Osmania Medical College, Spinal cord injury, Private practice, American Board of Commissioners for Foreign Missions, Faculty, Brain, Public health, National Center for Spinal Disorders, Aneurysm, Patient, The North American, Rehabilitation, NIMS, MBBS, Continental, University of Florida Cancer and Genetics Research Complex, Science, Dentistry, MD

OCALA, Fla., Jan. 19, 2023 /PRNewswire/ -- Dr. Praveen Reddy is being recognized by Continental Who's Who as a Top Pinnacle Professional for his contributions in the medical field.

Key Points: 
  • OCALA, Fla., Jan. 19, 2023 /PRNewswire/ -- Dr. Praveen Reddy is being recognized by Continental Who's Who as a Top Pinnacle Professional for his contributions in the medical field.
  • He then completed a second fellowship in neuro-oncology, cerebrovascular and skull base surgery with Professor Ugur Ture.
  • Dr. Reddy worked in his private practice at Methodist Hospital in Minneapolis until 2018 and remained on faculty at the University of Minnesota.
  • In his free time, Dr. Reddy is an avid golfer who has been happily married to Mrs. Kiran Reddy for 26 years.

ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal Neuromodulation System to Evaluate its Safety and Effectiveness for Paralysis due to Spinal Cord Injury

Retrieved on: 
Thursday, February 2, 2023
Paralysis, NSR, Federation, Food, Safety, Spinal cord injury, Trial of the century, TSS, International Center, Physical medicine and rehabilitation, ICSCI, Education, Ascending limb of loop of Henle, Research, Physician, Patient, Spinal cord, Kennedy Krieger Institute, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Johns Hopkins School of Medicine, SCI, Neurostimulation, Rehabilitation, Medical device

– February 2, 2023 – Today, ANEUVO, a platform and therapy development company, has initiated a clinical study of the ExaStim® TSS system, a wirelessly-controlled neuromodulation system designed to deliver transcutaneous spinal cord stimulation (TSS).

Key Points: 
  • – February 2, 2023 – Today, ANEUVO, a platform and therapy development company, has initiated a clinical study of the ExaStim® TSS system, a wirelessly-controlled neuromodulation system designed to deliver transcutaneous spinal cord stimulation (TSS).
  • Transcutaneous Spinal Stimulation is an emerging neuromodulation therapy with the potential to help individuals living with spinal cord injury improve motor function.
  • ExaStim® therapy delivers stimulation to the spinal cord to modulate neural networks, which enables improvement in motor function.
  • Early research indicates that non-invasive spinal stimulation may help individuals with spinal cord injuries regain lost motor function and improve functional independence.

Allsup Employment Services Expert Joins United Spinal Association For Virtual Event On Feb. 9, 2023

Retrieved on: 
Friday, January 20, 2023
United Spinal Association, Senior Community Service Employment Program, AES, Spinal cord injury, Social Security, Disorder, Social, Disability, Ontario Disability Employment Network, TTW, Health insurance, Ticket

Belleville, Illinois, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Allsup Employment Services (AES) Director Diane Winiarski will be featured as part of the United Spinal Association’s Pathways to Employment Program during a virtual presentation from 3-4 p.m. Eastern Time on Thursday, Feb. 9, 2023.

Key Points: 
  • Belleville, Illinois, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Allsup Employment Services (AES) Director Diane Winiarski will be featured as part of the United Spinal Association’s Pathways to Employment Program during a virtual presentation from 3-4 p.m. Eastern Time on Thursday, Feb. 9, 2023.
  • During this free virtual event, vocational rehabilitation expert Winiarski will discuss the Social Security Administration’s Ticket to Work (TTW) program and employment opportunities for people with spinal conditions.
  • “I am delighted to represent AES for this very important discussion on the Ticket to Work program, as well as the services we provide as a Social Security-approved Employment Network,” Winiarski said.
  • The virtual event covering the Ticket to Work Program will be held from 3-4 p.m. Eastern Time on Thursday, Feb. 9, 2023.